Você procurou por: meningococcal (Inglês - Dinamarquês )

meningococcal septicaemia
meningokok-sepsis

protection against meningococcal disease
beskyttelse mod meningokoksygdom

conjugated to meningococcal protein2 50 micrograms
konjugeret til meningokokprotein2 50 mikrogram

bexsero is a meningococcal group b vaccine.
bexsero er en meningokok gruppe b-vaccine.

the most serious side effect was meningococcal sepsis.
den alvorligste bivirkning var blodforgiftning forårsaget af meningokokker.

received a meningococcal vaccination with a written confirmation
fået en meningokokvaccination med skriftlig bekræftelse heraf,

meningococcal group a, c, w135 and y conjugate vaccine
meningokokgruppe a, c, w135 og y konjugeret vaccine

vaccination may not be sufficient to prevent meningococcal infection.
vaccination beskytter ikke nødvendigvis tilstrækkeligt til at forhindre meningokokinfektion.

meningococcal group b vaccine (rdna, component, adsorbed)
meningokok gruppe b-vaccine (rdna, komponent, adsorberet)

effect of prior vaccination with plain polysaccharide meningococcal vaccine
virkningen af tidligere vaccination med almindelig polysakkarid meningokokvaccine

patients received meningococcal vaccination prior to receipt of soliris.
patienterne fik meningokokvaccine før administration af soliris.

bexsero meningococcal group b vaccine (rdna, component, adsorbed)
bexsero meningokok gruppe b-vaccine (rdna, komponent, adsorberet)

if available, tetravalent, conjugated vaccines are recommended (see meningococcal disease).
det anbefales at anvende en tetravalent, konjugeret vaccine, hvis en sådan forefindes (se meningokoksygdom).

cases of serious or fatal meningococcal infections have been reported in soliris-treated patients.
tilfælde af alvorlige eller letale meningokokinfektioner er rapporteret hos patienter behandlet med soliris.

there was an un-vaccinated patient diagnosed with idiopathic membranous glomerulonephropathy who experienced meningococcal meningitis.
meningokokmeningitis forekom hos én uvaccineret patient med diagnosticeret idiopatisk membranøs glomerulonefritis.

haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine
haemophilus b-konjugat (meningokok proteinkonjugat) og hepatitis b (rekombinant) -vaccine

the most serious adverse event was meningococcal septicaemia in two vaccinated pnh patients (see section 4.4) .
den alvorligste bivirkning var meningokokseptikæmi hos to vaccinerede pnh-patienter (se pkt.4. 4) .

bexsero is not expected to provide protection against all circulating meningococcal group b strains (see section 5.1).
bexsero forventes ikke at beskytte mod alle cirkulerende meningokok gruppe b-stammer (se pkt.

procomvax suspension for injection haemophilus b conjugate (meningococcal protein conjugate) and hepatitis b (recombinant) vaccine
procomvax injektionsvæske, suspension haemophilus b- konjugat (meningokok proteinkonjugat) og hepatitis b (rekombinant) - vaccine

the most common adverse reaction was headache (occurred mostly in the initial phase), and the most serious adverse reaction was meningococcal sepsis.
den hyppigst indberettede bivirkning var hovedpine (forekom hovedsageligt i opstartsfasen), og den alvorligste infektion var meningokoksepsis.